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Abstract
International guidelines recommend routine hospital admission for all patients with mild 
traumatic brain injury (TBI)  who have injuries on CT brain scan. Only a small proportion of 
these patients require neurosurgical or critical care intervention. We aimed to develop an 
accurate clinical decision rule to identify low risk patients safe for discharge from the 
emergency department (ED) and facilitate earlier referral of those requiring intervention. 
A retrospective cohort study of case-notes of patients admitted with initial GCS13-15 and 
injuries identified by CT was completed. Data on a primary outcome measure of clinically 
important deterioration (indicating need for hospital admission) and secondary outcome of 
neurosurgery, ICU admission or intubation (indicating need for neurosurgical admission) 
were collected. Multivariable logistic regression was used to derive models and a risk score 
predicting deterioration using routinely reported clinical and radiological candidate 
variables identified in a systematic review. We compared the performance of this new risk 
score with the Brain Injury Guideline (BIG) criteria, derived in the USA. 
1699 patients were included from 3 English Major Trauma Centres. 27.7% (95% CI: 25.5% to 
29.9%) met the primary, and 13.1% (95% CI: 11.6% to 14.8%) met the secondary, outcome 
of deterioration. The derived clinical decision rule suggests that patients with simple skull 
fractures or intracranial bleeding less than 5mm in diameter who are fully conscious could 
be safely discharged from the Emergency Department. The decision rule achieved a 
sensitivity of 99.5% (95% CI: 98.1% to 99.9%) and specificity of 7.4% (95% CI: 6% to 9.1%) to 
the primary outcome.  The BIG criteria achieved the same sensitivity but lower specificity 
(5%). 
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Our empirical models showed good predictive performance and outperformed the BIG 
criteria. This would potentially allow ED discharge of one in twenty patients currently 
admitted for observation. However prospective external validation and economic evaluation 
is required.
Key Words:
Mild Traumatic Brain Injury; Prognostic modelling; Intra-cranial haemorrhage; Minor Head 
Injury.
Background
Over 1.4 million patients annually attend Emergency Departments (EDs) in the UK following 
head trauma of which ninety-five percent have a normal or mildly impaired conscious level 
at presentation -  Glasgow Coma Scale (GCS) score of 13-15.1 The majority of Emergency 
Department Computed Tomography (CT) scans for diagnosing Traumatic Brain Injury (TBI) 
are conducted in these patients with apparently mild injury. In this group the prevalence of  
brain injuries, skull fractures and intracranial bleeding  is 7%, whilst only 1% of CT scans 
identify life-threatening TBI.2 
The management of patients with mild TBI and injuries identified by CT imaging is 
controversial. Some centres advocate that all patients should be admitted under specialist 
neurosurgical care and undergo repeat CT imaging.3, 4 The Brain Injury Guideline criteria 
(BIG), a consensus derived risk tool currently used in some centres in the USA, advocate the 
discharge of selected GCS 13-15 patients from the ED  with injuries on CT (Supplementary 
Material 1).5 We recently published a systematic review of predictors of deterioration in this 
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cohort identifying some single factors associated with deterioration, but there was no good 
empirical evidence to guide post imaging management in this group4.
In England national (National Institute of Health and Clinical Excellence - NICE) head injury 
guidelines recommend  that patients with TBI identified by CT are admitted to hospital.1 
However, they do not define which injuries are clinically significant and which patients  
benefit from specialist neurosurgical care. Other guidelines used internationally also 
recommend routine hospital admission for this group.4
There has been a paucity of research to inform the admission and referral decisions for 
these TBI patients with apparently mild injuries but abnormalities on CT scan.6 Prediction 
modelling may help identify low risk patients who could be safely discharged from the ED. 
Modelling may also facilitate earlier identification of patients requiring neurosurgical 
intervention. 
The study aims were to:
I. Estimate the prevalence of clinically important deterioration in GCS1315 patients 
with traumatic CT abnormalities.
II. Develop prediction models for patient deterioration that could be used to triage 
hospital admission and specialist referral.
III. Compare the performance of an empirically derived prediction model with the BIG 
criteria.
Methods
Study Design
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We conducted a retrospective cohort study using case note review of TBI patients 
presenting to the ED between 2010-2017 at three Major Trauma Centres in England: Hull 
University Teaching Hospital NHS Trust, Salford Royal NHS Foundation Trust and 
Addenbrookes Hospital (Cambridge University Hospitals NHS Foundation Trust). A detailed 
study protocol has previously been published.6 The study was conducted and is reported in 
accordance with international guidelines for prognostic research.7
Study Population
Population selection
Within each study centre ED, CT brain scan requests and reports were screened to identify 
patients with traumatic findings presenting between 2010-17. Patients were matched to 
case records and if meeting the inclusion criteria data were extracted on patient 
deterioration outcomes and candidate predictors (see below).
Inclusion Criteria
Patients aged ≥16 with a presenting GCS 13-15 who attended the ED following acute head 
trauma and had  injuries reported on  CT brain scan. The latter was defined as: skull 
fractures, extradural haemorrhage, subdural haemorrhage with an acute component, intra-
cerebral haemorrhage, contusions, subarachnoid haemorrhage and intra-ventricular 
haemorrhage. Intra-cerebral, intra-ventricular and subarachnoid haemorrhages were 
considered traumatic in aetiology when a mechanism of injury or injuries indicating trauma 
were recorded.
Exclusion Criteria
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Patients were excluded where: a non-traumatic cause of intra-cranial haemorrhage was 
indicated,  pre-existing CT abnormality prevented determining whether acute injury had 
occurred and patients transferred from other hospitals.
Outcomes
Primary Outcome
Ddeterioration up to 30 days following ED attendance was used which was a composite 
including: death attributable to TBI, neurosurgery, seizure, a drop in GCS>1, ICU admission 
for TBI, intubation or hospital readmission for TBI. Where reason for death, ICU admission 
or readmission was unknown it was attributed to TBI  deterioration.
Secondary Outcome
A composite measure indicating need for neurosurgical specialist admission was used 
including: neurosurgery, ICU admission for TBI or intubation up to 30 days following ED 
attendance. 
Predictors
Pre-injury anticoagulant and antiplatelet therapy were combined in a variable with two 
categories: i) no therapy and ii) use of either or both medications (exploratory multivariable 
modelling indicated they had similar effect sizes). Comorbidity was measured using the 
trauma modified Charlson comorbidity index. 8 Rockwood frailty scale scores were assigned 
to patients over 50 years using information in the case notes and data collapsed into 
established categories.9, 10 
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Supplementary Material 2 outlines how injuries described in written CT reports were 
categorised. Injuryies severity was were coded using the abbreviated injury scale (AIS), 
injury size and presence of midline shift or mass effect. AIS codes were mapped to the 
Marshall classification using the method described by Lesko et al and the description of 
midline shift.11 An additional category of severity of up to 2 injuries with a combined 
maximal diameter less than 5 mm was added. TBI severity, as measured by the Marshall 
classification,11 was assessed for inclusion in the final model alongside type of haemorrhage, 
contusion or skull fracture present and the total number of injuries. This allowed the 
independent predictive value of each of these components of the CT scan to be 
simultaneously assessed.
Sample Size
A sample size requirement of 2000 patients was calculated using an estimated prevalence of 
deterioration of 10%.6 Interim analysis found the actual prevalence of deterioration to be 
around 25%. Therefore the target was revised to 1700 patients, equating to 425 events and 
allowing 42 candidate factors to be assessed on the basis of 10 events per factor.12  
Statistical analysis
Model Selection
The primary and secondary outcomes of deterioration were modelled as binary variables 
using logistic regression.13 We used stepwise selection to find the smallest number of 
candidate explanatory variables that accurately predict deterioration.  Table 2 summarises 
how candidate variables were included in modelling. For each candidate predictor an 
unadjusted odds ratio was calculated.
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The extent of missing data on each candidate variable is shown in Table 1. Where 
medication use was undocumented it was taken to indicate no pre-injury use. For other 
variables we assumed missing data occurred at random. 25 imputed data sets were created 
(based on missing data in around 25% of cases) using chained equations including all 
candidate variables and outcomes in the ICE STATA package.14  The midiagplots STATA 
function was used to compare the distributions of observed and imputed data.15 Where 
continuous variables were non-normally distributed and implausible imputed values were 
generated, predictive mean matching was used.14 
Model selection was performed using multivariable backward elimination with a statistical 
significance threshold of 0.1.  All candidate predictors were initially included and imputed 
data sets combined using Rubins rules at each stage of model selection. For candidate 
continuous variables, rather than assume a linear relationships, the best predictive form 
was explored with the MFPMI function using backward elimination for fractional polynomial 
functions in multivariable modelling.16 17 Fractional polynomials were limited to 2 degrees of 
freedom when predicting the secondary outcome.
Model performance
Model fit was assessed using the Briers score averaged across imputed data sets.18 A score 
of 0 implies perfect prediction and 0.25 no predictive value.
Model discrimination (how well patients with and without deterioration were distinguished) 
was assessed by the C-statistic, measured by combing estimates across imputed data sets 
using Rubins rules.17, 19 
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Calibration measures how well predictions made by models match observations.13 The 
calibration slope of selected predictors was calculated in each imputed data set and 
averaged. 
Sensitivity analysis
Model selection and evaluation of model performance was repeated in patients with 
complete data.
Internal validation
Models tend to perform better on data from which they are derived (overfitting).13  
Bootstrap internal validation with 100 bootstrap samples was performed in each imputed 
data set to calculate the average optimism. Model selection was repeated in each bootstrap 
sample and performance of models selected was subtracted by performance in the original 
data set.20, 21 The pooled average difference in the calibration slope between the bootstrap 
samples and original data was averaged across imputed data sets. This was subtracted from 
the original averaged calibration slope to estimate the shrinkage factor. The shrinkage factor 
was applied to the derived model coefficients to adjust for optimism.13 The C statistic was 
adjusted for optimism using the same method.
Mild TBI Risk score development and comparison to the BIG criteria
To use our prognostic model for making to clinical decisions we derived a risk score using 
optimism adjusted coefficients.22 To make the risk score clinically interpretable coefficients 
were standardised and rounded.22 Individual patient risk scores were calculated. A risk score 
for ED discharge was proposed based on the trade-off between risk of deterioration in a 
discharged patient and number of patients admitted for observation.
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Sensitivity and specificity of the proposed discharge score and of the BIG criteria to 
deterioration were calculated and compared in patients with complete data for both 
criteria.
Ethics
NHS Research Ethics Committee Approval was granted by West of Scotland REC 4 reference: 
17/WS/0204. As a retrospective case review conducted by members of the direct care team, 
consent was not requited.
Results 
Study population
Figure 1 summarises study population selection and Table 1 population characteristics and 
candidate variables. The cohort was mostly male, with around half of patients aged over 60 
and quarter with either pre-injury anti-coagulant or anti-platelet use. 470 patients (27.7%; 
95% CI: 25.5% to 29.9%) clinically deteriorated as defined by the primary outcome. 223 
patients (13.1%; 95% CI: 11.6% to 14.8%) underwent neurosurgery, were admitted to ICU or 
were intubated (secondary outcome). 72 patients had deaths attributable to TBI. 471 
patients had data missing from at least one candidate variable.
Model selection
Table 2 summarises the univariable associations between candidate variables and the 
primary outcome. Supplementary material 3 presents the distributions of imputed data. 
The equivalent of 41 candidate factors were assessed in multivariable modelling to predict 
patient deterioration and 34 factors were assessed in modelling to predict need for 
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neurosurgical referral. The selected model predicting the primary outcome is presented in 
Table 2 and the secondary outcome in Table 3. Supplementary Material 4 presents a 
complete case sensitivity analysis. 
Model Performance
Table 4 summarises measures of model performance. The models predicting the primary 
and secondary outcomes had Briers scores of 0.16 and 0.09 respectively. The model 
predicting composite deterioration (primary outcome) had an optimism-adjusted C-statistic 
of 0.75 and the model predicting need for specialist neurosurgical admission had an 
optimism-adjusted C-statistic of 0.85. The trade-off between the sensitivity and specificity of 
these models is shown in the ROC curves in Supplementary Material 5.
The mild TBI Risk Score 
Table 5 presents the weighted risk score derived from our prognostic model predicting 
deterioration. Haemoglobin, although a statistically significant predictor in multivariable 
modelling was not included as, due to the small effect size and range of abnormal values, 
inclusion did not improve performance (Supplementary Mate ial 6). Based on the trade-off 
between sensitivity and specificity, a patient risk score of 0 was used as a threshold for ED 
discharge. Patients as this cut off had the following characteristics: initial GCS15, single 
simple skull fracture or haemorrhage<5mm, up to 2 extra-cranial bony or organ injuries not 
requiring hospital admission, not anticoagulated/taking antiplatelets, no cerebellar/brain 
stem injuries, and normal neurological examination (Table 5).  Patients with a risk score of 1-
5 had a 17.5% risk of deterioration and patients with a risk score >5 had 54% risk of 
deterioration (Supplementary material 7)
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The performance of the BIG criteria and our risk score were assessed in the 1569 patients 
with complete data for both classification systems. A threshold of 0 in our risk score 
achieved a sensitivity of 99.5% (95% CI: 98.1% to 99.9%) and specificity of 7.4%  (95% CI: 6% 
to 9.1%) to the primary outcome. The BIG criteria for discharge achieved the same 
sensitivity for deterioration but lower specificity (Table 6). Table 6 summarises the 
characteristics of the false negatives (patients  meeting the discharge threshold who 
deteriorated) in both approaches. No patients recommended for discharge by either 
criteria, died or required neurosurgery, but 1 patient recommended for discharge by the BIG  
criteria required intubation. The BIG criteria would have allowed discharge of 57 patients 
(3.6%) compared to 87 patients (5.5%) with our risk score. 
Discussion
Summary
To our knowledge, this is the first UK study to report the risk of deterioration in all initial 
mild TBI patients with traumatic injuries reported on CT brain scan and study internationally 
to develop a prognostic model and risk tool for avoiding unnecessary hospital admissions. 
We also report the first independent validation of the BIG criteria.
The estimated prevalence of deterioration was 27.7%. Our prognostic models for composite 
measures of deterioration had optimism adjusted C statistics of 0.75 and 0.85, indicating 
good discrimination between patients with and without deterioration or need for 
neurosurgical care.
Using our risk score, derived from the prognostic model, to hypothetically direct need for  
hospital admissions we identified that it would appear safe to discharge from the 
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Emergency Department patients who are fully conscious with no focal neurology (GCS15)  
not taking anticoagulant or antiplatelet medication who have with a single simple skull 
fracture or haemorrhage<5mm (not cerebellar or brainstem) on CT brain scan and up to two 
extra-cranial bony or organ injuries not requiring hospital admission (risk score 0). This 
derived decision rule, achieved a sensitivity of 99.5% and specificity of 7.4% for 
deterioration. Categorisation of patients for discharge using the BIG criteria achieved the 
same sensitivity but a lower specificity.
The model predicting need for neurosurgical admission (based on risk of an interventional 
outcome) found higher age and frailty reduces risk. This probably reflects clinical selection 
of patients, with frail older patients less likely to undergo invasive interventions. 
Strengths 
We believe this is the largest multi-centre cohort study undertaken to estimate the 
prevalence of a composite measure of deterioration in this population.4 The study was  
powered to develop a prognostic model predicting this outcome. Candidate predictor 
factors were selected a priori on the basis of existing literature.6 We followed established 
techniques for handling missing data, prognostic modelling and adjusting for optimism.7, 13, 
16, 23 Unlike risk stratification systems based solely upon CT findings,24-26 we have assessed a 
range of additional patient characteristics, test results and other clinical factors for 
deterioration for inclusion in our model so as to achieve the maximum predictive accuracy. 
Our risk score is the first empirically derived scoring system which can to be used to inform 
admission decisions in this TBI population and incorporates both patient characteristics and 
other clinical risk factors alongside CT findings.
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Limitations
Due to the resource implications of conducting a prospective study we pragmatically chose 
a retrospective study design. Around 25% of patients had missing data, but as these data 
were mainly missing through poor recording or missing notes, and therefore missing at 
random, imputation techniques were valid. Documentation inaccuracies may have 
introduced random error but are unlikely to have introduced systematic bias. 
We classified TBI severity using information in written CT reports by using AIS coding to map 
to a modified Marshall classification. Poor reporting of the size of injuries and extent of 
mass effect meant most injuries were classified as equivalent to Marshall classification II. 
Better systematic and standardised reporting may have allowed TBI severity to be better 
classified and improved the performance of the derived models. We were unable to assess 
whether using other scoring systems to classify TBI severity such as the Stockholm, Helsinki 
or NIRIS scoring systems would improve the performance of the derived model. 24-26 Unlike 
with the Marshall classification, there is no validated way to map between AIS coding and 
these classification systems. However, type of injury was considered for inclusion in the 
model, alongside the Marshall classification and number of injuries
Outcomes were limited to those recorded in hospital records, which may mean that patient 
deterioration in the community was missed. However, this is unlikely and a check in Hull of 
deaths recorded in patients eligible for entry on the national trauma registry (linked to 
office of national statistic mortality reporting) found no missed deaths.
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We only assessed the predictive value of routinely collected factors. We could not assess 
the potential predictive value of  using non-routinely collected variables identified in our 
review6 or biomarkers. 
Although we have internally validated our derived models, they have not been externally 
validated. There is debate about the best way to combine imputation of missing data and 
internal validation bootstrapping techniques.21 We chose to bootstrap within imputations 
due to lower computational complexity. This has been shown in simulation studies to 
provide accurate estimates of the shrinkage factor.21 Other studies27 found imputing within 
bootstraps better adjusts for optimism and therefore despite adjusting for overfitting, our 
models may perform less well when applied to new data. 
The lower prevalence of the secondary outcome than expected means our study may not be 
adequately powered to derive a model accurately predicting this outcome. 
Comparison Previous literature
The estimated prevalence of clinical deterioration at 27.7% was higher than previously 
reported. In our review we found the pooled prevalence of clinical deterioration to be 
around 10% .4  This reflects differences in study design; previous studies used narrower 
outcome definitions, such as neurological deterioration or ICU intervention,4 whilst we used 
a wide composite primary outcome aimed at encompassing need for hospital admission. We 
assessed an unselected GCS13-15 population, whilst previous studies often restricted their 
inclusion criteria on the basis of GCS scores, injury severity, admitting inpatient specialty 
and medication use.6
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Research assessing prognostic factors in this TBI population have frequently used sample 
sizes based on convenience and lacked the statistical power to assess potential predictors 
simultaneously.4, 28  Our study was sufficiently powered to assess over 40 candidate 
variables in multivariable modelling. Previous research found initial GCS, type of brain injury, 
anti-coagulation and age were the strongest predictors of adverse outcomes in this 
population.4 In our multivariable model all these factors were also found to be predictors of 
deterioration.  
Studies evaluating the BIG criteria in the Level 1 trauma centre in the USA, where it is 
routinely applied, found around 10% of patients met the criteria for ED discharge and no 
patient that met these criteria had adverse outcomes.5, 29 In our cohort 4% of patients met 
the criteria for ED discharge and two of these patients deteriorated. Our study cohort was 
on average older and had a lower GCS than studies previously assessing the BIG criteria, 
which may account for the difference in performance.  
Implications
Internationally, and particularly in the USA, there is wide variation in admission practices in 
this group with a range of specialist admission and discharge criteria used on the basis of 
limited evidence.5, 30-32 Accurate risk prediction has the potential to help rationalise 
admission decisions in this group. Between April 2014 and June 2015 around 11, 000 TBI 
patients were admitted to specialist neurosurgical centres in the UK and over 50% of these 
patients had mTBI.33 Currently all patients with TBI identified by CT imaging are admitted to 
hospital. Consequently, any risk stratification tool which could safely reduce unnecessary 
admissions may save significant health service resources.Therefore, despite the low 
specificity of our model and the high false positive rate, application of our model could 
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improve clinical care by reducing unnecessary hospital admissions and thereby save health 
service resources and reduce patient inconvenience.  Internationally, and particularly in the 
USA, there is wide variation in admission practices in this group with a range of specialist 
admission and discharge criteria used on the basis of limited evidence.5, 30-32 Accurate risk 
prediction has the potential to help rationalise admission decisions in this group.
Our risk tool demonstrated good predictive accuracy (99.5% sensitivity (99.5%) to our 
primary outcome) at the proposed threshold for ED discharge. This would have allowed the 
discharge of 87/1569 patients (5.5%). At this sensitivity a negative predictive value of 97.7% 
was achieved (about a 1 in 50 chance of a discharged patient deteriorating). This may not be 
clinically acceptable, but no patient recommended by our risk score for discharge died, 
required neurosurgery or an ICU intervention. One patient recommended for discharge had 
a report indicating a possible second lesion, and therefore may have been admitted in 
clinical practice. The BIG criteria achieved the same sensitivity (99.5%) to the primary 
outcome but its lower specificity means clinical application would result in fewer patients 
being discharged.
The high predictive accuracy of our model for the secondary outcome (AUC = 0.85) suggests  
it could be used to triage neurosurgical admissions in this population. The acceptable level 
of risk of requiring invasive intervention for a patient admitted under a non-specialist team 
is unknown and is likely to vary between centres. The lower prevalence of this outcome 
means the estimated model may be less accurate and we regard this as a starting point for 
further research. 
Both our prognostic model and the BIG criteria should be validated prospectively before 
they could be used in clinical practice. A prospective study design would address the 
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weaknesses in outcome collection highlighted earlier, including assessing the predictive 
value of CT severity classification systems other than the Marshall classification system, and 
allow the inclusion of non-routinely collected prognostic factors including biomarkers.  
Improved systematic reporting of CT scans could possibly increase the predictive accuracy of 
our model and further increase the performance of our  risk tool.25, 34 Economic evaluation 
is also required to comprehensively assess the implication for both patient outcomes and 
resource use of using the model.
Conclusion
This is the first study to empirically derive a prognostic model for patients with mTBI and 
injuries identified by CT imaging and independently validate the BIG criteria. Our empirically 
derived risk tool performed better than the BIG criteria and could be used to safely 
discharge from the ED one in twenty patients currently routinely admitted for observation. 
Both our prognostic model and the BIG criteria now require prospective external validation 
and economic evaluation.
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Table 1: Characteristics of the study population
Table 2: Candidate factors (uni and multi-variable) associations with the outcome of deterioration
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Table 3:  Candidate factors (uni and multi-variable) association with neurosurgical admission
Table 4: Performance of predictive models
Table 5:Mild TBI Risk score 
Table 6: P rformance of mTBI risk score and BIG criteria
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Table 1: Characteristics of the study population
Candidate  Factor Category Mean (SD), min-max
OR N (%)
Missing data
N=1699 
Age Years 58.2 (SD 23.3)
16-101
Age≥65 = 44.9%
None
Sex Male
Female
67% (Median Age= 52)
33% (Median Age= 69)
None
GCS 15
14
13
976 (58%)
533 (31%)
185 (11%)
5 (0.3%)
Mechanism of Injury Assault
Fall
Fall from height 
RTC
Sport
Other
228 (13%)
1090 (64%)
361 (21%)
298 (18%)
21  (1%)
30 (2%)
31 (1.8%)
Intoxicated Yes 494 (29%) 38 (2.2%)
Seizure pre-hospital or 
in ED
Yes 74 (4%) 10 (0.6%)
Vomit pre-hospital or in 
ED
Yes 310 (18%) 12 (0.7%)
Preinjury Anti-
coagulation or anti-
platelets
Anticoagulation use
Antiplatelet use
Both
155 (9%)
294 (17.3%)
8 (0.5%)
None
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Abnormal First 
Neurological 
Examination
Yes 233 (14.5%) 89 (5.2%)
Initial Blood pressure Mean Arterial Pressure 
mmHG
98.5 (SD 17)
43-193
61 (3.6%)
Initial Oxygen Saturation % 97.4 (SD 2.4)
80-100
59 (3.5%)
Initial Respiratory Rate RR per Min 17.9 (SD 3.5)
10-48
94 (5.5%)
Haemoglobin Grams/litre 136 (SD 19.1)
68-265
211 (12.4%)
Platelet Value 109/L 232 (SD 77)
2-742
211 (12.4%)
Number of Injuries on 
CT
1
2
3
4
5
Multiple diffuse injury*
824 (48.5%)
400 (23.6%)
217 (12.7%)
142 (8.4%)
103 (6.1%)
13 (0.8%)
None
Injury severity on CT
(Modified Based on the 
Marshall Classification 
system and described in 
detail supplementary 
Material 2)
1) Simple Skull Fractures
2) Complex Skull 
fractures
3)1-2 bleeds < 5mm 
(total)
4) No or minimal mass 
effect
5) Significant midline 
shift
66 (3.9%)
123 (7.2%)
208 (12.2%)
1001 (58.9%)
159 (9.4%)
122 (7.2%)
22 (1.2%)
None
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6) High/mixed-density 
lesion**
7) Cerebellar/Brain stem 
injury
Skull Fracture (simple) Yes 316 (19%) None
Skull Fracture (complex) Yes 360 (21%) None
Contusion Yes 580 (34%) None
Extradural bleed Yes 135 (8%) None
Intraparenchymal 
haemorrhage
Yes 240 (14%) None
Subdural bleed Yes 694 (41%) None
Intra-ventricular bleed Yes 50 (3%) None
Subarachnoid bleed Yes 536 (32%) None
Rockwood Clinical Frailty 
Scale (CFS)
Patients under 50
CFS 1-3
CFS 4-6
CFS 6-9
649 (39%)
642 (38%)
308 (18.5%)
72 (4.5%)
28 (1.6%) cases
Comorbidity Charlson Index 1.4 (SD 2.9)
0-28 (range)
20 (1.2%) cases
ISS Body regions excluding 
head
5.2  (SD 5.2)
0-75 (range)
None
   *diffuse injuries refer to multiple tiny intracerebral haemorrhages/contusions/diffuse axonal 
injuries
**This category corresponds to Marshall Classification VI (volume>25mls) and corresponds to a need 
for surgical evacuation by the Marshall Classification.
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Table 2: Candidate factors  uni and multi-iable) associations ith the outcome of deterioration
Candidate  Factor Category Ui	i
le effect on 
	ir  	ioration : 
Odds ratio (95% CI)
Multivariable effect on 
risk of deterioration: 
Odds Ratio (95% CI)
GCS Vs 15 GCS14
GCS13
1.8 (1.4 to 2.3)
3.1 (2.3 to 4.4)
1.6 (1.2 to 2.1)
2.3 (1.6 to 3.3)
Preinjury Anti-
coagulation or anti-
platelets
Yes 1.7 (1.3 to 2.1) 1.4 (1.03 to 1.8)
Abnormal Neurological 
Examination
Abnormal 2.3  (1.7 to 3) 1.7  (1.2  to  2.3)
Haemoglobin Grams/litre (1 unit increase) 0.99  (0.98  to  0.99) 0.99 ( 0.98 to 1)
Number of Injuries on 
CT
Vs 1
2
3
4
5
Diffuse injury
1.4 (1.1 to 1.9)
1.8 (1.3 to 2.5)
3.2 ( 2.2 to  4.7)
3.7 (2.5  to  5.7)
1.1  ( 0.3 to 4.2)
1.3 (0.97 to 1.8)
1.6 (1.1 to 2.3)
2.5 (1.6 to 3.8)
2.8 (1.7 to 4.6)
1.4  (0.3 to 5.3)
Injury severity on CT
Vs simple skull fracture
(categories described in 
detail supplementary 
material 2)
2) Complex Skull fractures
3)1-2 bleeds < 5mm (total)
4) No or minimal mass effect
5) Significant midline shift
6) High/mixed-density lesion
7) Cerebellar/Brain stem injury
1.4 (0.5 to 4.2)
1.4 (0.5 to 3.8)
4 (1.6 to 10)
13.7 (5.2 to  35.8)
40.1 (15 to 111.9)
8.1 (2.3 to 29.2)
1.4 ( 0.5 to 4.3)
1.1 (0.4 to 3.1)
2.3 (0.9 to 5.9)
6.8 (2.5 to 18.5)
21.6 (7.7 to 60.7)
7 (1.9 to 25.7)
Extracranial Injury ISS 1 unit increase 1.02 (1.00 to 1.04) 1.03 (1.002 to 1.05)
Age Year 1 unit increase 1.01 (1.006 to 1.015) *
Sex Female 1.04 (0.83  to 1.31) *
Intoxicated Yes 0.98 (0.77 to 1.24) *
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Seizure pre-hospital or 
in ED
Yes 1.2 (0.7  to  2) *
Vomit pre-hospital or in 
ED
Yes 1.3 (1 to 1.7) *
Initial Blood pressure 1 unit increase, Mean Arterial 
Pressure mmHG
1.004 (1 to  1.01) *
Initial Oxygen Saturation % (1 unit increase) 0.99 (0.95 to 1.04) *
Initial Respiratory Rate RR per Min (1 unit increase) 1.05 (1.02 to  1.08) *
Platelet Value 109/L (1 unit increase) 1  (0.997  to  1) *
Skull Fracture (Simple) Yes 1.1 (0.8 to 1.4) *
Skull Fracture (Complex) Yes 0.955 (0.7 to 1.2) *
Contusion Present Yes 1.4 (1.1 to 1.7) *
Extradural bleed Yes 2 (1.4 to 2.9) *
Intraparenchymal 
haemorrhage Present
Yes 1.2 (0.9 to 1.6) *
Subdural bleed Yes 2.2 (1.8 to 2.8) *
Intra-ventricular bleed Yes 1.9 (1.81to 3.4) *
Subarachnoid bleed Yes 1.4 (1.1 to 1.7) *
Comorbidity Charlson Index 1.07  (1.03 to  1.11) *
Rockwood Frailty Score
Vs under 50
CFS 1-3
CFS 4-6
CFS 7-9
1.3 (1.04 to 1.7)
1.6 (1.2 to 2.2)
2.8 (1.7 to  4.6)
*
* Not selected into model
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Table 3:  Candidate   uni and multiariable) associatio th neurosurgical admission
Candidate  Factor Category !"#"$le effect on 
#%& '( )+,+#ioration : 
Odds ratio (95% CI)
Multivariable effect on 
risk of deterioration: 
Odds Ratio (95% CI)
Age Year (1 unit increase) 0.99 (0.99  to 1) (Age/10)3 
Fractional 
Polynomial
0.997 
(0.996  to 
0.9989
GCS Vs 15 GCS14
GCS13
2 (1.5 to 2.8)
3.8 (2.6 to 5.7)
2.3 (1.6 to 3.3)
3.7 (2.3 to 5.9)
Abnormal Neurological 
Examination
Abnormal 2.4  (1.7  to  3.4) 1.9  (1.3 to 3)
Haemoglobin Grams/litre (1 unit increase) 1  (0.99  to  1.01) 0.99  (0.98  to  1)
Injury severity on CT
Vs simple skull fracture
(categories described in 
detail supplementary 
material 2)
2) Complex Skull fractures
3)1-2 bleeds < 5mm (total)
4) No or minimal mass effect
5) Significant midline shift
6) High/mixed-density lesion
7) Cerebellar/Brain stem injury
1.9 (0.4 to 9.6)
1 (0.2 to 4.8)
3.3 (0.8 to 13.6)
11.5 (2.7 to  49)
41.7 (9.8 to 178)
8 (1.3 to 47.6)
0.9 (0.5 to 4.9)
0.8 (0.1 to 4.1)
2.3 (0.5 to 9.7)
7.4 (1.6 to  33.9)
37.1 (8.1 to 169)
8.5 (1.3 to 56.2)
Skull Fracture (Complex) Yes 1.7 ( 1.3 to 2.3) 2 (1.3 to 3)
Subdural bleed Yes 2.2 (1.6 to  2.9) 1.7 (1.2 to  2.5)
Extracranial Injury ISS (1 unit increase) 1.03 (1.004 to 1.06) 1.06 (1.03 to 1.09)
Rockwood Frailty Score
Vs under 50
CFS 1-3
CFS 4-6
CFS 7-9
1.2 (0.9 to 1.6)
0.4 ( 0.2 to 0.7)
0.09 (0.01 to 0.6)
1.9 (1.1 to 3.1)
0.7 (0.3 to 1.8)
0.09 (: 0.01 to  0.7)
Sex Female 0.66 (0.48  to 0.91) *
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Preinjury Anti-
coagulation or anti-
platelets
Yes 0.95 (0.7  to 1.3) *
Intoxicated Yes 1.1 (0.8 to 1.5) *
Seizure pre-hospital or 
in ED
Yes 1.8 (0.99  to  3.18) *
Vomit pre-hospital or in 
ED
Yes 1.5 (1.1 to 2.1) *
Initial Blood pressure 1 unit increase, Mean Arterial 
Pressure mmHG
1.006 (1 to  1.01) *
Initial Oxygen Saturation % (1 unit increase) 1 (0.94 to 1.07) *
Initial Respiratory Rate RR per Min (1 unit increase) 1  (0.99 to  1.07) *
Platelet Value 109/L (1 unit increase) 0.99 ( 0.998  to  1.001) *
Number of Injuries on 
CT
Vs 1
2
3
4
5
Diffuse injury
1.4 (0.98  to  2.1)
1.5 (1 to  2.4)
3.4 (2.2 to  5.3)
4.3 (2.7 to  7)
1.8  (0.4  to  8.3)
*
Skull Fracture (Simple) Yes 1.2  (0.8 to  1.7) *
Contusion Present Yes 1.3 (0.997 to 1.8) *
Extradural bleed Yes 2.6 (1.7 to  3.9) *
Intraparenchymal 
haemorrhage Present
Yes 0.7 (0.5 to  1.2) *
Intra-ventricular bleed Yes 0.7 (0.3 to  1.9) *
Subarachnoid bleed Yes 1.4 (1 to  1.9) *
Comorbidity Charlson Index (1 unit increase) 0.94 (0.89 to 1) *
*Not Selected into model
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Table 4: .erformance of predictiv/ models
Outcome Measure Apparent 
./rformance
Av/rage 
Optimism
Optimism 
Adjusted
Clinical Deterioration Brier 
Score
0.16
Calibration 
Slope
1 0.14 0.86
C-statistic 0.773 0.026 0.747
Need for 01ecialist 
neurosurg2cal 
admission
Brier 
Score
0.09
Calibration 
Slope
1 0.04 0.96
C-statistic 0.86 0.01 0.85
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Table 5: Mild 345 67sk score 
F89;<r Coefficient 
(op;imism adjusted)
Risk Score =alue 
Preinjury Anti-coagulation or 
anti-platelets
  0.3 1
GCS
15
14
13
  0 (Vs)
0.4
0.7
G>S ?@  0 
G>S ?B  1
G>S ?C  2
Normal first Neurological 
Examination 
  0.45 Abnormal 1.5
Number of  Injuries on CT
?
D  
C 
B 
5   
Diffuse 
  0 (Vs)
0.25
0.4
0.8
0.9
0.3
? 0
D 1
C 1
B 3
5 3
Diffuse 1
Injury severity on CT*
? simple skull fracture
D complex Skull Fracture
C 1-2 bleeds < 5mm
B No or minimal mass effect 
  0 (Vs)
0.3
0.08
0.7
? 0
D 1
C 0
B 2
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5 Significant midline shift 
E High/mixed-density lesion 
7 Cerebellar/Brain stem injury 
1.7
2.7
1.7
5 5
E 9
7 5
ISS (body regions excluding 
head)
  0.2 HI tJ K LJLMNOPLOQORSLt exTVSM
cranial injurieNWW                0
XLY NOPLOficaLT nxtraMRranial 
injurY or Z or more injuries      2
Hb -0.01 Not included in risk score
Constant -1.38
*TBI severity categories are described in detail in Supplementary material 2
** Injuries exclude superficial lacerations and abrasions and a significant extra-cranial injury is 
defined as any injury requiring inpatient care
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Tabl[ \] ^[rformance of _`ab risk score and aIG criteria
N=1cdf Deteriorated Didnh jeteriorate ^kqthtu[ ^wedictive yzl{e (^^y|
}[~zhtve ^wedictive yzlue (N^y|
^[rformance of Risk score
Admission 
(Score
 1059 V = 28.5%
Discharge 
(Score=<0)
2* 85 NPV = 97.7%
Sensitivity= 99.5% 
(95% CI: 98.1% to 
99.9%)
Specificity= 7.4% 
(95% CI: 6% to 9.1%)
^[rformanc[ k ab witeria
Admit (not BIG1) 423 1089 PPV = 28%
Discharge (BIG 1) 2* 55 NPV = 96.5%
Sensitivity = 99.5% 
(95% CI: 98.1% to 
99.9%)
Specificity= 4.8% 
(95% CI: 3.7% to 
6.3%)
*Patients  recommended for  discharge by our risk score who deteriorated:  
1) 85 female, small subdural dropped GCS. Rockwood frailty score 4. 
2) 56 male, small contusion (report stated possible 2nd small intra-cranial haemorrhage, only first 
injury included) and pre-injury seizure. Seizure during admission.
Patients triaged to discharge by BIG who deteriorated:  
1) 85 female, small subdural dropped GCS. Rockwood frailty score 4. 
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2) 55 female, small subdural and poly trauma (ISS 10). Required intubation.
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Figure 1: Population Selection 
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1
STROBE Statement—Checklist of items that should be included in reports of cohort studies 
Item 
No Recommendation
(a) Indicate the study’s design with a commonly used term in the title or the abstract 
Page 1
 Title and abstract 1
(b) Provide in the abstract an informative and balanced summary of what was done 
and what was found
Page 3
Introduction
Background/rationale 2 Explain the scientific background and rationale for the investigation being reported
Page 4,5
Objectives 3 State specific objectives, including any prespecified hypotheses
Page 5
Methods
Study design 4 Present key elements of study design early in the paper
Page 5
Setting 5 Describe the setting, locations, and relevant dates, including periods of recruitment, 
exposure, follow-up, and data collection
Page 5
(a) Give the eligibility criteria, and the sources and methods of selection of 
participants. Describe methods of follow-up Page 6
Participants 6
(b) For matched studies, give matching criteria and number of exposed and 
unexposed
Variables 7 Clearly define all outcomes, exposures, predictors, potential confounders, and effect 
modifiers. Give diagnostic criteria, if applicable Page 5 -10
Data sources/ 
measurement
8*  For each variable of interest, give sources of data and details of methods of 
assessment (measurement). Describe comparability of assessment methods if there is 
more than one group Page 7 -8
Bias 9 Describe any efforts to address po ential sources of bias Page 8-10
Study size 10 Explain how the study size was arrived at Page 8
Quantitative variables 11 Explain how quantitative variables were handled in the analyses. If applicable, 
describe which groupings were chosen and why Page 9-10
(a) Describe all statistical methods, including those used to control for confounding 
Page 8 -10
(b) Describe any methods used to examine subgroups and interactions
(c) Explain how missing data were addressed Page 8,9
(d) If applicable, explain how loss to follow-up was addressed 
Statistical methods 12
(e) Describe any sensitivity analyses Page 10
Results
(a) Report numbers of individuals at each stage of study—eg numbers potentially 
eligible, examined for eligibility, confirmed eligible, included in the study, 
completing follow-up, and analysed  Page 11-13
(b) Give reasons for non-participation at each stage
Participants 13*
(c) Consider use of a flow diagram Fig 1
(a) Give characteristics of study participants (eg demographic, clinical, social) and 
information on exposures and potential confounders Table 1
(b) Indicate number of participants with missing data for each variable of interest 
Table 1
Descriptive data 14*
(c) Summarise follow-up time (eg, average and total amount)
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2
Outcome data 15* Report numbers of outcome events or summary measures over time
(a) Give unadjusted estimates and, if applicable, confounder-adjusted estimates and 
their precision (eg, 95% confidence interval). Make clear which confounders were 
adjusted for and why they were included Table 2 and Table 3
(b) Report category boundaries when continuous variables were categorized
Main results 16
(c) If relevant, consider translating estimates of relative risk into absolute risk for a 
meaningful time period
Other analyses 17 Report other analyses done—eg analyses of subgroups and interactions, and 
sensitivity analyses Supplementary Material 4
Discussion
Key results 18 Summarise key results with reference to study objectives Page 13
Limitations 19 Discuss limitations of the study, taking into account sources of potential bias or 
imprecision. Discuss both direction and magnitude of any potential bias Page 14-15
Interpretation 20 Give a cautious overall interpretation of results considering objectives, limitations, 
multiplicity of analyses, results from similar studies, and other relevant evidence
Page 16-17
Generalisability 21 Discuss the generalisability (external validity) of the study results
Page 15, 17
Other information
Funding 22 Give the source of funding and the role of the funders for the present study and, if 
applicable, for the original study on which the present article is based
Page 18, 19
*Give information separately for exposed and unexposed groups.
Note: An Explanation and Elaboration article discusses each checklist item and gives methodological background and 
published examples of transparent reporting. The STROBE checklist is best used in conjunction with this article (freely 
available on the Web sites of PLoS Medicine at http://www.plosmedicine.org/, Annals of Internal Medicine at 
http://www.annals.org/, and Epidemiology at http://www.epidem.com/). Information on the STROBE Initiative is 
available at http://www.strobe-statement.org.
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Supplementary Material 1: The Brain Injury Guideline (BIG) criteria:
BIG1 (Discharge from 
ED afte   urs)
¡¢£¤ ¥¦on-specialist 
 spital admission)
¡¢£§¨ ¥©ªecialist 
 spital admission)
Neurological 
«¬­®¯nation
£°©13-15
Normal pupils
No Focal Neurological 
deficit
£°©13-15
Normal pupils
No Focal Neurological 
deficit
£°©<13 
± ²bnormal pupils
± ³ cal Neurological 
deficit
Intoxicat d No ¦ ´µ¶· ¦ ´µ¶·
Anticoagulants or 
Anti-platelets
No No µ¶·
Skull Fracture No Non-displaced Displaced
Intracranial Bleed Subdural 
Haemor­¸¶ ¹º®® 
±
«¬»­¼½ral 
Haemor­¸¶ ¹º®®
±
1 Intraparen¾¿®­À
Haemor­¸¶ ¹º®® 
± Á­¾¶ 
SuÂ­­¾Ãoid 
Haemor­¸¶
Subdural 
Haemor­¸¶ ºÄÅ®m 
±
«¬»­¼½ral 
Haemor­¸¶ ºÄÅ®m
±
1-2 Intraparen¾¿®­À
Haemor­¸¶· ºÄÅ®® 
± Æ calised 
SuÂ­­¾Ãoid 
Haemor­¸¶
All  »¶ ¯Ãjuries
Intra-ventricular 
Haemor­¸¶
No No µ¶·
¨Ç­»¯¶Ã»· ®½·t fulfil all »¶ ¾iteri­  È ¡¢£É   ¡¢£¤ »  Âe categorised as suc and ar¶  »eÊ¯·¶
automatically in B¢£§
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Supplementary material 2: Categorisation of TBI severity
Category Injury Description 
written CT report
AIS Codes Equivalent 
Marshal 
Classification 
(Lesko et 
at11)
1 Vault skull fractures 150000, 150400 150402
2 Basal, depressed, 
open skull fractures
150200, 150204, 150205, 1502ËÌÍ ÎÏËÐËÐÍ ÎÏËÐËÌÍ ÎÏË408 I
3 1-2 Bleeds*  
/contusions total 
diameter <5mm 
140605, 140631, 140639, 140651, 140693, 140694 (and written 
CT report indicated injury <5mm)
4 Bleed/contusion
No or minor mass 
effect
140602,140604,140606,140612,140614,140611,140620,140622, 
140628,140629,140630,140632,140634,140638,140640,140642, 
140644,140646,140650,140652,140654,140684,140688, 
140686, 140699, 140676, 140678, 140680, 140682, 140799
II
5** Bleed/contusion 
Significant midline 
shift or mass effect 
indicated in CT report
140202, 140660, 140662, 140664, 140666 III/IV
6 Non-evacuated mass 
lesion.
High or mixed density 
mass lesion***
140608,140610,140616,140618,140624,140626,140636,140648, 
140656, 140637, 140655
VI 
7 Cerebellar/brainstem 
injury 
140204,140206,140208,140210,140212,140214,140218,140299,
140402,140403,140404,140405,140406,140410,140414,140418,
140422,140426,140430,140434,140438,140442,140446,140450,
140458,140462,140466,140470,140474,140499,
VII
*Bleeds refers to subdural, extradural, intracerebral and subarachnoid haemorrhage
**Written CT reports did not allow easy differentiation in the extent of mass effect, and therefore 
Marshall III and IV categories were collapsed into 1 category. 
***This category refers to any lesion or combination of lesions where the mass effect is so great that 
the Marshall Classification recommends immediate surgical intervention.
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Supplementary material 3: Distribution of observed and imputed data of first 6 imputations of 25
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Intoxication:
Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 29.7% 29.7% 29.7% 29.7% 29.7% 29.7%
Imputed 42.1% 34.2% 34.2% 39.5% 47.4% 36.8%
Completed 30% 29.8% 29.8% 30% 30.1% 29.9%
Prehospital or ED Seizure:
Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 4.4% 4.4% 4.4% 4.4% 4.4% 4.4%
Imputed 0% 22.3% 0% 11.1% 0% 11.1%
Completed 4.4% 4.5% 4.4% 4.4% 4.4% 4.4%
Prehospital or ED Vomiting:
Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 18.4% 18.4% 18.4% 18.4% 18.4% 18.4%
Imputed 8.3% 16.7% 16.7% 16.7% 33.3% 25%
Completed 18.3% 18.4% 18.4% 18.4% 18.5% 18.4%
GCS:
GCS:15 Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
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Observed 57.6% 57.6% 57.6% 57.6% 57.6% 57.6%
Imputed 60% 40% 60% 60% 80% 40%
Completed 57.6% 57.6% 57.6% 57.6% 57.6% 57.6%
GCS:14 Imputation 4 Imputation 2 Imputation 4 Imputation 4 Imputation 5 Imputation 6
Observed 31.5% 31.5% 31.5% 31.5% 31.5% 31.5%
Imputed 40% 40% 40% 40% 20% 60%
Completed 31.5% 31.5% 31.5% 31.5% 31.5% 31.5%
GCS:13 Imputation 4 Imputation 2 Imputation 4 Imputation 4 Imputation 5 Imputation 6
Observed 10.9% 10.9% 10.9% 10.9% 10.9% 10.9%
Imputed 0% 20% 0% 0% 0% 0%
Completed 10.9% 10.9% 10.9% 10.0% 10.9% 10.0%
Abnormal First Neurological Examination:
Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 14.5% 14.5% 14.5% 14.5% 14.5% 14.5%
Imputed 14.6% 30.3% 21.3% 21.3% 19.1% 13.5%
Completed 14.5% 15.3% 14.8% 14.8% 14.7% 14.4%
Frailty (no missing data under 50 category):
Under 50 Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 38.8% 38.8% 38.8% 38.8% 38.8% 38.8%
Imputed 10.7% 7.1% 7.1% 7.1% 10.7% 10.7%
Completed 38.4% 38.3% 38.3% 38.3% 38.4% 38.4%
CFS 1-3 Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 38.4% 38.4% 38.4% 38.4% 38.4% 38.4%
Imputed 64.3% 75% 75% 75% 67.9% 64.3%
Completed 38.8% 39% 39% 39% 38.9% 38.8%
CFS 3-6 Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 18.4% 18.4% 18.4% 18.4% 18.4% 18.4%
Imputed 17.9% 14.3% 14.3% 17.9% 17.9% 17.9%
Completed 18.4% 18.4% 18.4% 18.4% 18.4% 18.4%
CFS 7-9 Imputation 1 Imputation 2 Imputation 3 Imputation 4 Imputation 5 Imputation 6
Observed 4.3% 4.3% 4.3% 4.3% 4.3% 4.3%
Imputed 7.1% 3.6% 3.6% 0% 3.6% 7.1%
Completed 4.4% 4.3% 4.3% 4.2% 4.3% 4.4%
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Supplementary Material 4:  Multivariable Models selected in complete case analysis  
Candidate  Factor Category Multivariable effect on 
risk of deterioration: 
Odds Ratio (95% CI)
Multivariable effect on 
risk of deterioration: 
Odds Ratio (95% CI)
Age Year (1 unit increase) * (Age/10)3
Fractional 
Polynomial
0.997 
(0.996  to 
0.999
GCS Vs 15 GCS14
GCS13
1.5 (1.1 to 2.1)
2.7 (1.8 to 4.1)
1.6 (1 to 2.5)
4.2 (2.4 to 7.2)
Abnormal Neurological 
Examination
Abnormal 1.4  (0.99 to  2.1) 2.1  (1.3 to 3.5)
Injury severity on CT
Vs simple skull fracture
(categories described in 
detail supplementary 
material 2)
2) Complex Skull fractures
3)1-2 bleeds < 5mm (total)
4) No or minimal mass effect
5) Significant midline shift
6) High/mixed-density lesion
7) Cerebellar/Brain stem injury
1.3 ( 0.4 to 4.5)
0.7 (0.2 to 2.2)
1.8 (0.6 to 5.4)
5.6 (1.8 to 17.5)
14.4 (4.4 to 46.6)
10.1 (2 to 49.8)
1.3 (0.2 to 7.2)
0.6 (0.1 to 3.6)
2.3 (0.5 to 10.2)
11 (2.3 to  52)
47.4 (9.9 to 227.5)
10.5 (1.2 to 89.3)
Subdural bleed Yes 1.8 (1.3 to 2.4) *
Extracranial Injury ISS (1 unit increase) * 1.06 (1.03 to 1.1)
Rockwood Frailty Score
Vs under 50
CFS 1-3
CFS 4-6
CFS 7-9
* 1.4 (0.8 to 2.6)
0.6 (0.2 to 1.7)
0.1 ( 0.01 to  1.05)
Preinjury Anti-
coagulation or anti-
platelets
Yes 1.3 (1 to 1.8) *
Intoxicated Yes * 0.6 (0.4 to 0.95)
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Number of Injuries on 
CT
Vs 1
2
3
4
5
Diffuse injury
* 0.9 (0.5 to 1.5)
0.7 (0.4 to 1.4)
1.6 (0.8 to 3.1)
2.5 (1.2 to  5.1)
2.1 (0.2 to 18.4)
Contusion Present Yes 1.3 (0.99 to 1.8) *
Extradural bleed Yes 1.7 (1 to 2.8) *
Intraparenchymal 
haemorrhage Present
Yes * 0.5 (0.2 to  0.9)
Intra-ventricular bleed Yes 1.9 (0.9 to 3.9) *
*Not Selected into model
Supplementary Material 5:
a) ROC curve of derived model for  osite outcome of deterioration for dr
from  e ¡¢
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b) ROC curve of derived model for secondar£ c¤¥¦¤site outcome of deterioration indicati§¨
need for ©¦ecialist §ª«¬¤©«¬¨­®¯° admission
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*AUC estimated in patients with complete data for explanatory variables in each model
Supplementary Material 6: Performance of risk score including Hb
±¯®²¤r Coefficient 
(o¦²imism adjusted)
Risk Scorª ³alue 
Preinjury Anti-coagulation or 
anti-platelets
  0.3 1
GCS
15
14
13
  0 (Vs)
0.4
0.7
GCS ´µ  0 
GCS ´¶  1
GCS ´·  2
Normal first Neurological 
Examination 
  0.45 Abnormal 1.5
Number of  Injuries on CT
´
¸  
· 
¶ 
5   
Diffuse 
  0 (Vs)
0.25
0.4
0.8
0.9
0.3
´ 0
¸ 1
· 1
¶ 3
5 3
Diffuse 1
Injury severity on CT*
´ simple skull fracture   0 (Vs) ´ 0
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2 complex Skull Fracture
3 1-2 bleeds < 5mm
4 Marshall II
5 Marshall II/IV
¹ Marshall VI
º Brain stem/Cerebellar
0.3
0.08
0.7
1.7
2.7
1.7
» 1
¼ 0
½ 2
5 5
¹ 9
º 5
ISS (body regions excluding 
head)
  0.2 ¾¿ tÀ » ÁÀÁÂÃÄÅÁÄÆÄÇÈÁt eÉÊËÈÂ
cranial inÌurieÃÍÍ 0
ÎÁÏ ÃÄÅÁÄficaÁÊ ÐÉtraÂÇranial 
inÌurÏ or ¼ or ÑÀËÐ iÁÌÒËies      2
Hb -0.01 ÓÔÕÖ× 2
Constant -1.38
N=1370 ØÐteriorated ØÄÙÁÚÊ Ùeteriorate ÛÀÃÄÊÄÜÐ ÛËedictive 
ÝÈÞÒe (ÛÛÝß
àÐÅÈÊÄve ÛËedictive 
ÝÈÞÒe (àÛÝß
ÛÐrforÑÈÁce of Risk score
Admission 
(Score>0)
396 912 PPV=30.3% 
Discharge 
(Score=<0)
2 60 NPV=96.8%
Sensitivity = 99.5% 
(95% CI: 98% to 99.9%)
Specificity= 6.2% 
(95% CI: 4.8% to 7.9%)
Supplementary material 7: risk stratification by risk score
Risk ácore × ÖÂâ ãâ
Deteriorated 2 181 242
Did not deteriorate 85 855 204
Prevalence 
deterioration
2.3% 15.5% 54%
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